Evidence map›Paper›PMID 36712835›Full record

ArticlePLOS global public health2022

"She is the one who knows": A qualitative exploration of oral and injectable PrEP as part of a community empowerment approach to HIV prevention among female sex workers in the Dominican Republic and Tanzania.

Andrea Mantsios, Ohvia Muraleetharan, Yeycy Donastorg, Martha Perez, Hoisex Gomez, Catherine Shembilu, S Wilson Beckham, Tahilin Sanchez Karver, Wendy Davis, Samuel Likindikoki and 3 more

Open access · goldAbstract read
In one paragraph

Article in PLOS global public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Andrea MantsiosPublic Health Innovation & Action, New York, New York, United States of America.ORCID 0000-0002-3314-9173
Ohvia MuraleetharanYale School of Public Health, New Haven, Connecticut, United States of America.ORCID 0000-0002-3256-4535
Yeycy DonastorgDepartment of Health Policy, Instituto Dominicano de Dermatologia y Cirugia de Piel, Santo Domingo, Dominican Republic.
Martha PerezDepartment of Health Policy, Instituto Dominicano de Dermatologia y Cirugia de Piel, Santo Domingo, Dominican Republic.
Hoisex GomezDepartment of Health Policy, Instituto Dominicano de Dermatologia y Cirugia de Piel, Santo Domingo, Dominican Republic.
Catherine ShembiluDepartment of Psychiatry, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
S Wilson BeckhamDepartment of Health, Behavior and Society, Johns Hopkins University, Baltimore, Maryland, United States of America.ORCID 0000-0002-9694-3091
Tahilin Sanchez KarverDepartment of Health, Behavior and Society, Johns Hopkins University, Baltimore, Maryland, United States of America.ORCID 0000-0001-7362-9377
Wendy DavisDepartment of Prevention and Community Health, George Washington University, Washington, DC, United States of America.ORCID 0000-0003-4521-0688
Samuel LikindikokiDepartment of Psychiatry, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Jessie MbwamboDepartment of Psychiatry, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Clare BarringtonDepartment of Health Behavior, University of North Carolina, Chapel Hill, North Carolina, United States of America.
Deanna KerriganDepartment of Prevention and Community Health, George Washington University, Washington, DC, United States of America.ORCID 0000-0001-7401-9159
Instituto Dermatológico y Cirugía de Piel "Dr. Huberto Bogaert Díaz" · DOMuhimbili University of Health and Allied Sciences · TZGeorge Washington University · USJohns Hopkins University · USUniversity of North Carolina at Chapel Hill · US

Funding

Research Services CoreP2CHD050924 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KAREN B GUZZO · 2015 to 2026
$9.6M
Stigma, Cohesion and HIV Outcomes Among Vulnerable Women Across Epidemic SettingsR01MH110158 · NIMH · JOHNS HOPKINS UNIVERSITY · PI KERRIGAN, DEANNA L · 2016 to 2020
$3.6M
Preferences for PrEP in Tanzanian Women at Heightened Risk of HIV InfectionK01MH114715 · NIMH · JOHNS HOPKINS UNIVERSITY · PI COLE, SAM WILSON · 2017 to 2021
$732k
NICHD NIH HHS P2C HD050924NIMH NIH HHS K01 MH114715NIMH NIH HHS R01 MH110158
6 · The paper itself

Abstract

Despite documented interest among female sex workers (FSW), uptake of oral pre-exposure prophylaxis (PrEP) for HIV prevention has been low. Recent trials and regulatory approval of long-acting injectable (LAI) PrEP offer new hope for the potential of this biomedical intervention. We examined FSW's PrEP-related interest and preferences regarding both oral and LAI PrEP situating these dynamics within their specific social and occupational realities. We conducted this work using qualitative methods across two distinct contexts by conducting 40 in-depth interviews with FSW in Tanzania and the Dominican Republic. Textual data was coded using iterative thematic content analysis. Analytic summaries were developed and reviewed to identify recurring themes. We systematically organized themes within each country and then compared across settings. Women in both settings expressed strong interest in PrEP seeing it as an important option to protect themselves in their work. Most participants preferred LAI PrEP due to expectations of reduced stigma and concerns about daily pill adherence and side effects. Occupational factors such as alcohol use, overnight dates with clients, and fear of violence from clients were identified as barriers to daily oral PrEP. LAI PrEP was seen as having the potential to reduce stress related to oral PrEP. Women who preferred pills discussed fear of needles, skepticism about the injections, and others relayed that taking a daily pill would not be challenging for them. There was a pre-dominant sentiment that women know best whether they are better suited for oral or LAI PrEP. Participants stressed the importance of FSW understanding both options to ensure informed decision-making around PrEP and described community-led peer education as key to delivering trusted information. Community empowerment approaches led by FSW which address structural and psychosocial constraints and promote safe work environments may facilitate equitable access and uptake of PrEP among FSW across settings.

Identifiers

PMID36712835
PMCPMC9880901
OpenAlexW4295952527

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.